Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (XBI) where we have detected an approximate $88.8 million dollar inflow — that’s a 2.1% increase week over week in outstanding units (from 47,350,000 to 48,350,000). Among the largest underlying components of XBI, in trading today Mirati Therapeutics Inc (MRTX) is off about 2.9%, Portola Pharmaceuticals, Inc. (PTLA) is up about 0.7%, and Sage Therapeutics Inc (SAGE) is higher by about 1.5%. For a complete list of holdings, visit the XBI Holdings page »
The chart below shows the one-year price performance of XBI, versus its 200 day moving average:
Looking at the chart above, XBI’s low point in its 52 week range is $64.38 per share, with $101.55 as the 52 week high point.
The SPDR S&P Biotech ETF (XBI) was trading at $90.23 per share on Wednesday afternoon, up $1.40 (+1.58%). Year-to-date, XBI has gained 6.38%, versus a 5.08% rise in the benchmark S&P 500 index during the same period.
This article is brought to you courtesy of ETF Channel.